Jennifer Pietenpol Archives
Jul. 9, 2020—The Vanderbilt Institute for Infection, Immunology and Inflammation (VI4) recently moved into its new research and administrative home.
May. 21, 2020—More than a dozen representatives of Vanderbilt University Medical Center helped plan and made a commitment to help carry out the strategy for how Tennessee will prevent cancer and minimize its burden on state residents.
Mar. 12, 2020—Researchers from Vanderbilt-Ingram Cancer Center (VICC) discovered a role for MYCN in triple-negative breast cancer (TNBC), a particularly aggressive form of the disease, and identified a potential intervention for further clinical investigation.
Feb. 27, 2020—Researchers at VUMC are reporting another advance in the understanding and treatment of triple-negative breast cancer, which is particularly aggressive and difficult to treat.
Oct. 24, 2019—Two Vanderbilt-Ingram Cancer Center investigators have received financial support from Susan G. Komen for breast cancer research.
Apr. 18, 2019—StrategyShare19, an annual, interactive event at Vanderbilt University Medical Center to showcase innovations and initiatives to advance the Medical Center’s Strategic Directions, is focusing this year on Design for Patients and Families — one of the four Strategic Directions — and efforts to enhance patient, clinician and staff experiences.
Jun. 28, 2018—Jun. 28, 2018—A multidisciplinary cross section of the Vanderbilt University Medical Center and Vanderbilt University community gathered Tuesday during StrategyShare18, an interactive half-day event to share ideas, invite collaborations and spur new initiatives.